Literature DB >> 7492750

Efficient immortalization of rheumatoid synovial tissue B-lymphocytes. A comparison between the techniques of electric field-induced and PEG fusion.

V Krenn1, P von Landenberg, E Wozniak, C Kissler, H K Hermelink, U Zimmermann, H P Vollmers.   

Abstract

In this study, B-cells isolated from rheumatoid synovial tissue were immortalized, without prior in vitro stimulation, by means of electric-field induced fusion and conventional PEG fusion in order to compare the efficiency of these methods. Two myeloma cell lines were used as fusion partners, the murine myeloma Ag8 and the murine-human heteromyeloma HAB-1. The results of seven fusion experiments performed simultaneously with identical cell populations showed that fusion frequencies obtained by electrofusion were 4 to 35 times higher than by the PEG fusion technique. The morphological and immunohistochemical evaluation of synovial tissues used for fusion showed that only tissues exhibiting a follicular distribution of B-cells with a high percentage of CD 22-positive lymphocytes gave rise to high fusion yields and produced B-cell clones, whereas synovial tissues with the same percentage of plasma cells but lower percentages of CD 22 lymphocytes yielded very low fusion rates. In conclusion, electrofusion is more efficient for immortalizing small amounts of synovial tissue B-lymphocytes than PEG fusion, since high fusion frequencies could be obtained by this technique without the need for prior in vitro stimulation. Synovial tissue exhibiting a follicular distribution of B-lymphocytes with high percentages of CD 22-positive lymphocytes gave rise to high hybridoma yields and therefore an ideal source of human rheumatoid B-cell clones.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492750

Source DB:  PubMed          Journal:  Hum Antibodies Hybridomas        ISSN: 0956-960X


  6 in total

1.  Molecular analysis of rheumatoid factor (RF)-negative B cell hybridomas from rheumatoid synovial tissue: evidence for an antigen-induced stimulation with selection of high mutated IgVH and low mutated IgVL/lambda genes.

Authors:  V Krenn; A König; F Hensel; C Berek; M M Souto Carneiro; W Haedicke; Y Wang; H Vollmers; H K Müller-Hermelink
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

2.  Immunohistochemical analysis of proliferating and antigen-presenting cells in rheumatoid synovial tissue.

Authors:  V Krenn; N Schalhorn; A Greiner; R Molitoris; A König; F Gohlke; H K Müller-Hermelink
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

3.  Immortalized B-lymphocytes from rheumatoid synovial tissue show specificity for bacterial HSP 60.

Authors:  V Krenn; H P Vollmers; P von Landenberg; B Schmausser; M Rupp; A Roggenkamp; H K Müller-Hermelink
Journal:  Virchows Arch       Date:  1996-02       Impact factor: 4.064

Review 4.  Specific immunotherapy of cancer in elderly patients.

Authors:  S Matzku; M Zöller
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 5.  Tissue-associated autoantigens in rheumatoid arthritis. Tissue-antigens detected by autoantibodies in synovial fluid and sera of RA patients.

Authors:  P von Landenberg; J Schölmerich
Journal:  Clin Rev Allergy Immunol       Date:  2000-02       Impact factor: 10.817

Review 6.  Exploring the native human antibody repertoire to create antiviral therapeutics.

Authors:  S K Dessain; S P Adekar; J D Berry
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.